Reluctance to vaccination: a person’s journey from one company to almost no. . But not quite. . . Yes
Phyllis Kimber Wilcox | Black Voice News
America is gaining ground when it comes to the number of people who have chosen to be vaccinated. While many have chosen to do so, there are still many who haven’t. As a result, vaccine hesitation is discussed everywhere.
What does “hesitation” mean and what impact will it have on efforts to stop the pandemic?
Reluctance to vaccination is described as reluctance to take one or more vaccines. Lately, the term is also used to describe those who have received the first dose of one of the available COVID-19 vaccines but do not return for the follow-up dose.
There is concern that people’s refusal to be vaccinated or to receive full doses of available vaccines may prevent the development of herd immunity. What constitutes herd immunity differs, but current estimates indicate that between seventy and eighty percent of the population would need to be vaccinated to achieve the goal of herd immunity.
The reluctance to get vaccinated has not only affected members of the general population, but members of Congress as well. According to an article by The hill only seventy-five percent of members of Congress have been vaccinated, slowing efforts to ease coronavirus restrictions on Capitol Hill.
There are three COVID-19 vaccines available for use in the United States. All three have different efficacy rates and vaccine requirements:
Pfizer’s vaccine requires two injections and is 95 percent effective, although the Centers for Disease Control and Prevention (CDC) study shows a 90 percent lower effective rate. This vaccine was recently approved by the Food and Drug Administration (FDA) for people aged 12 to 15 years.
The Moderna vaccine requires two injections and is 94.1% effective, although it is less effective for patients sixty years of age and older. Efficiency in this age group is only 86.4 percent.
The Johnson & Johnson vaccine requires only one injection and has an overall efficacy of 64%, although it has been shown to be more effective, 82%, against severe COVID-19 disease in South Africa or the B1 variant. 351 was detected for the first time.
Additional concern about Johnson & Johnson
Recently, the FDA suspended the use of the Johnson and Johnson vaccines, fearing that they could cause blood clots in rare cases. A safety label has been added to the vaccine to warn of this possibility. Recently, the FDA is investigating the death of a Michigan woman who received the Johnson & Johnson vaccine. According to an article by clickondetroit, “Over 6.8 million doses of the Johnson & Johnson vaccine have been administered in the United States, and these adverse events appear to be extremely rare. ”
There have also been production issues with the Johnson & Johnson vaccine, including contamination and sanitation issues at the Baltimore plant.
It is not known to what extent persistent challenges with the Johnson & Johnson vaccine impacted reluctance to the COVID-19 vaccine.
There is also interest in low-income and rural communities receiving the Johnson & Johnson vaccine which requires a single injection but has a much lower rate of effectiveness than other vaccines that have been distributed to people in the income brackets. higher.
Alex Reed, data analyst at Black Voice News, recently spoke about the difference.
“California actually released a very comprehensive vaccine scorecard. [In] that dashboard that they don’t necessarily list where – as in places – all of their vaccines go; but they establish it by quartiles, metric quartiles of vaccine equity. Measuring vaccine equity is actually a combination of two things. ”
The first is a Health Equity Metric, which is a whole different project under the auspices of the California Department of Public Health. “He looks at each individual community and how it compares to other communities across all these health data points like obesity, access to clinics, insurance, smoking rates, all of those types of things. . He [also] takes into account age, number of people in the home who do not speak English, etc. And then it says, “Your community is healthier or worse than ninety-five percent of the other communities.”
According to Reed, the government has taken the health equity measure and combined it with some of its COVID-19 data. Based on that information, she explained, they produced the vaccine fairness measure, released it, and labeled it by quartiles – one to four – from least healthy to healthier. The figures reflect the percentages of people who were fully vaccinated or who received the first injection in each of these quartiles.
“If you take a close look at the state’s vaccine scorecard, you’ll notice that the least healthy communities in the first quartile are behind the healthiest. [communities] in the fourth quartile of ten or fifteen percent. She noted that the CDC also had fairly comprehensive COVID-19 dashboards.
According to Reed, while you can’t see where vaccines are distributed on the state’s vaccine dashboard, they do have unpublished charts that show vaccine requests by county – this is reflected in the dashboard. COVID-19 which she created for Black Voice News titled “COVID and Black California: How COVID-19 Has Affected Black Bodies Over the Past Year. ”
Reed noted that the CDC released administration rates using the same metrics or quartiles and while you can’t see the rates by county on its dashboard, you can see them by quartiles. The most vulnerable and least healthy communities are those that received the highest rate of Johnson & Johnson vaccine.
Skip the second dose
According to The New York Times eight percent of those who received a first dose of currently available vaccines did not return for the second dose.
Meanwhile, the California Department of Public Health reports, “The state is tracking individuals who are beyond the 42-day window for their second dose, but the data is not readily available. “
On May 5, 2021, President Biden signaled his willingness to temporarily suspend patents on coronavirus vaccines to make them readily available to countries struggling with the pandemic.
In a statement, United States Trade Representative Katherine Tai said, “The administration strongly believes in intellectual property protections, but in service of ending this pandemic, supports waiving such protections for vaccines COVID-19. We will actively participate in. . . negotiations at the World Trade Organization should achieve this.
I spoke with Thomas (a pseudonym), a young man in his twenties, about his concerns about the vaccine. He said, “At first it was a no. “
He laughs to himself “No. I’m fine. I will only do this if it’s mandatory… You know. It’s been a serious situation and if the jobs were like “No you can’t work unless you have it” then I’d be like okay, I’m going to have it. “
This has been Thomas’ attitude since he first heard about COVID-19 vaccines. But, his attitude towards vaccination is starting to change.
“Now I lean more towards the Yes because number one — loved ones. My grandmothers on both sides, haven’t seen them for a minute and the only way I can see them is to have this [shot] and it’s been a while since COVID lasted. “
Thomas continued, “People got the hang of it and they talked about getting the shot. So, I feel a little more comfortable, and I know a few people, a friend or even some of my family. [who have gotten it]. My grandparents had it, so I feel a little more comfortable.
Part of Thomas’ change of mind may be due to his mother. “In fact, my mom said the same thing when her mom asked her, ‘Hey, when are you going to get him? [the vaccine] so I can see you? ‘ Time flies, Thomas insisted. “So we all think of getting there. I lean more for yes now.
Phyllis Kimber-Wilcox is a reporter for Black Voice News. His interests are the intersections of historical events with contemporary realities and their impacts on the lingering social, structural and economic barriers that continue to affect and limit the lives of black people for the sake of community solutions.